ArticlePharmacology research & perspectives2015

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine.

Roberta Gualdani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.